These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. Bunting PS, Goel V, Williams JI, Iscoe NA. CMAJ; 1999 Jan 12; 160(1):70-5. PubMed ID: 9934349 [Abstract] [Full Text] [Related]
4. Prostate specific antigen testing in men older than 75 years in the United States. Scales CD, Curtis LH, Norris RD, Schulman KA, Albala DM, Moul JW. J Urol; 2006 Aug 12; 176(2):511-4. PubMed ID: 16813879 [Abstract] [Full Text] [Related]
5. Age-specific patterns of prostate-specific antigen testing among primary care physician visits. McNaughton Collins M, Stafford RS, Barry MJ. J Fam Pract; 2000 Feb 12; 49(2):169-72. PubMed ID: 10718695 [Abstract] [Full Text] [Related]
7. Attitudes and practices of primary care physicians for prostate cancer screening. Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Am J Prev Med; 1996 Feb 12; 12(4):277-81. PubMed ID: 8874692 [Abstract] [Full Text] [Related]
8. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK. Clin Ther; 2009 Aug 12; 31(8):1859-70. PubMed ID: 19808145 [Abstract] [Full Text] [Related]
10. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database. D'Ambrosio GG, Campo S, Cancian M, Pecchioli S, Mazzaglia G. Eur J Cancer Prev; 2010 Nov 12; 19(6):413-6. PubMed ID: 20679895 [Abstract] [Full Text] [Related]
13. Mass screening for prostate cancer in Korea: a population based study. Song C, Ahn H, Lee MS, Park J, Kwon TG, Kim HJ, Choi HY, Korean Urological Oncology Society. J Urol; 2008 Nov 12; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541 [Abstract] [Full Text] [Related]
15. Screening for prostate cancer: a comparison of urologists and primary care physicians. McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC. South Med J; 1996 Sep 12; 89(9):885-8. PubMed ID: 8790311 [Abstract] [Full Text] [Related]
16. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians. Kell JS. Can J Urol; 2010 Feb 12; 17 Suppl 1():18-25. PubMed ID: 20170597 [Abstract] [Full Text] [Related]
17. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario? Bunting PS. Clin Biochem; 2004 Oct 12; 37(10):898-903. PubMed ID: 15369721 [Abstract] [Full Text] [Related]
18. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM. J Urol; 2007 Feb 12; 177(2):499-503; discussion 503-4. PubMed ID: 17222618 [Abstract] [Full Text] [Related]
20. PSA testing in general practice. Little B, Ho KJ, Gormley G, Young M. Prostate Cancer Prostatic Dis; 2003 Feb 12; 6(2):154-8. PubMed ID: 12806375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]